These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2117987)

  • 21. One trial conditioning with apomorphine is blocked by cycloheximide.
    Silverman PB; Baruch NP; Schultz KA
    Pharmacol Biochem Behav; 1989 Nov; 34(3):663-4. PubMed ID: 2623022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats.
    Smith JR; Morgan M
    Gen Pharmacol; 1982; 13(3):203-7. PubMed ID: 6124481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
    Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
    Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.
    Campbell JC; Jeyamohan SB; De La Cruz P; Chen N; Shin D; Pilitsis JG
    Behav Brain Res; 2014 Dec; 275():114-9. PubMed ID: 25205367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA; Tse A; Ballermann M; Smith LK; Fouad K
    Eur J Neurosci; 2005 Aug; 22(3):735-44. PubMed ID: 16101755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditioning of the early behavioral response to apomorphine in the rotational model of Parkinson's disease.
    Burunat E; Castro R; Díaz-Palarea MD; Rodríguez M
    Eur J Pharmacol; 1988 Jan; 145(3):323-7. PubMed ID: 3127225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medial prefrontal cortex ERK and conditioning: Evidence for the association of increased medial prefrontal cortex ERK with the presence/absence of apomorphine conditioned behavior using a unique post-trial conditioning/extinction protocol.
    Sanguedo FVC; Samuels RI; Carey RJ; Carrera MP
    Behav Brain Res; 2019 Jun; 365():56-65. PubMed ID: 30779974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of forebrain commissurotomy on recovery from unilateral 6-OHDA lesions of the substantia nigra and circling induced by apomorphine.
    Steiner H; Morgan S; Huston JP
    Behav Brain Res; 1985 Oct; 17(3):245-9. PubMed ID: 3936512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A re-evaluation of the role of superior colliculus in turning behaviour.
    Di Chiara G; Morelli M; Imperato A; Porceddu ML
    Brain Res; 1982 Apr; 237(1):61-77. PubMed ID: 6804010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.
    García-Ramírez M; Aceves J; Arias-Montaño JA
    Behav Brain Res; 2004 Oct; 154(2):409-15. PubMed ID: 15313028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation.
    Leite Junior JB; de Mello Bastos JM; Samuels RI; Carey RJ; Carrera MP
    Behav Brain Res; 2019 Feb; 359():771-782. PubMed ID: 30114434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
    Aguiar LM; Nobre HV; Macêdo DS; Oliveira AA; Freitas RM; Vasconcelos SM; Cunha GM; Sousa FC; Viana GS
    Pharmacol Biochem Behav; 2006 Jul; 84(3):415-9. PubMed ID: 16844208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine.
    Lee JI; Shin HJ; Nam DH; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH; Lee WY
    J Korean Med Sci; 2001 Oct; 16(5):636-42. PubMed ID: 11641536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
    Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
    Carey RJ
    Brain Res; 1991 Dec; 568(1-2):205-14. PubMed ID: 1814568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.